Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis

D. Smíšková, O. Džupová, L. Moravcová, D. Pícha

. 2023 ; 55 (8) : 551-558. [pub] 20230615

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010816

BACKGROUND: The chemokine CXCL13 in cerebrospinal fluid (CSF) is used as a diagnostic marker of Lyme neuroborreliosis (LNB). However, the elevated levels in other non-borrelial CNS infections and the lack of a clearly defined cut-off value are limitations of the test. METHODS: In our prospective study, we evaluated CSF CXCL13 levels in patients with LNB (47 patients), tick-borne encephalitis (TBE; 46 patients), enteroviral CNS infections (EV; 45 patients), herpetic CNS infections (HV; 23 patients), neurosyphilis (NS; 11 patients) and controls (46 patients). The correlation of CXCL13 with CSF mononuclears was determined in all groups. RESULTS: Median CXCL13 was significantly higher in LNB group; however, the cut-off value of 162 pg/mL was also exceeded in 22% of TBE patients, 2% EV patients, 44% HV patients and in 55% patients with NS. Sensitivity and specificity were 0.83 and 0.78, respectively, with a Youden index of 0.62. CXCL13 was significantly correlated with CSF mononuclears (p = .0024), but the type of infectious agent had a greater influence on CXCL13 levels. CONCLUSIONS: Increased CXCL13 levels are useful for LNB diagnostics, but other non-purulent CNS infections causes should be considered if intrathecal synthesis of borrelia specific antibodies is not confirmed or clinical manifestations are atypical.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010816
003      
CZ-PrNML
005      
20230801132634.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/23744235.2023.2222178 $2 doi
035    __
$a (PubMed)37317698
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Smíšková, Dita $u Department of Infectious Diseases, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic $1 https://orcid.org/0000000156996474 $7 xx0139471
245    10
$a Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis / $c D. Smíšková, O. Džupová, L. Moravcová, D. Pícha
520    9_
$a BACKGROUND: The chemokine CXCL13 in cerebrospinal fluid (CSF) is used as a diagnostic marker of Lyme neuroborreliosis (LNB). However, the elevated levels in other non-borrelial CNS infections and the lack of a clearly defined cut-off value are limitations of the test. METHODS: In our prospective study, we evaluated CSF CXCL13 levels in patients with LNB (47 patients), tick-borne encephalitis (TBE; 46 patients), enteroviral CNS infections (EV; 45 patients), herpetic CNS infections (HV; 23 patients), neurosyphilis (NS; 11 patients) and controls (46 patients). The correlation of CXCL13 with CSF mononuclears was determined in all groups. RESULTS: Median CXCL13 was significantly higher in LNB group; however, the cut-off value of 162 pg/mL was also exceeded in 22% of TBE patients, 2% EV patients, 44% HV patients and in 55% patients with NS. Sensitivity and specificity were 0.83 and 0.78, respectively, with a Youden index of 0.62. CXCL13 was significantly correlated with CSF mononuclears (p = .0024), but the type of infectious agent had a greater influence on CXCL13 levels. CONCLUSIONS: Increased CXCL13 levels are useful for LNB diagnostics, but other non-purulent CNS infections causes should be considered if intrathecal synthesis of borrelia specific antibodies is not confirmed or clinical manifestations are atypical.
650    _2
$a lidé $7 D006801
650    12
$a Borrelia $7 D001898
650    _2
$a chemokin CXCL13 $x mozkomíšní mok $7 D054382
650    _2
$a prospektivní studie $7 D011446
650    _2
$a diferenciální diagnóza $7 D003937
650    12
$a lymská neuroborelióza $x diagnóza $x mozkomíšní mok $7 D020852
650    _2
$a mozkomíšní mok $7 D002555
655    _2
$a časopisecké články $7 D016428
700    1_
$a Džupová, Olga $u Department of Infectious Diseases, Third Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic
700    1_
$a Moravcová, Lenka $u Department of Infectious Diseases, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic
700    1_
$a Pícha, Dušan $u Department of Infectious Diseases, Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic
773    0_
$w MED00191578 $t Infectious diseases (London, England) $x 2374-4243 $g Roč. 55, č. 8 (2023), s. 551-558
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37317698 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132631 $b ABA008
999    __
$a ok $b bmc $g 1963315 $s 1197081
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 55 $c 8 $d 551-558 $e 20230615 $i 2374-4243 $m Infectious diseases $n Infect Dis (Lond) $x MED00191578
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...